Structure-guided optimization of SLC1A1/EAAT3-selective inhibitors targeting renal cancer metabolism.
Saved in:
| Title: | Structure-guided optimization of SLC1A1/EAAT3-selective inhibitors targeting renal cancer metabolism. |
|---|---|
| Authors: | Koochaki P; Department of Cancer Sciences, Cleveland Clinic Research, Cleveland, OH, USA., Qiu B; Department of Physiology & Biophysics, Weill Cornell Medicine, New York, NY, USA.; Howard Hughes Medical Institute, Weill Cornell Medicine, New York, NY, USA., Coker JA; Center for Therapeutics Discovery, Cleveland Clinic Research, Cleveland, OH, USA.; Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Case Western Reserve University, Cleveland, OH, USA., Earsley A; Department of Physiology & Biophysics, Weill Cornell Medicine, New York, NY, USA., Wang NS; Center for Therapeutics Discovery, Cleveland Clinic Research, Cleveland, OH, USA., Romigh T; Center for Therapeutics Discovery, Cleveland Clinic Research, Cleveland, OH, USA., Goins CM; Center for Therapeutics Discovery, Cleveland Clinic Research, Cleveland, OH, USA.; Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Case Western Reserve University, Cleveland, OH, USA., Salem C; Department of Cancer Sciences, Cleveland Clinic Research, Cleveland, OH, USA., Mi D; Vanderbilt Institute of Chemical Biology, Vanderbilt University, Nashville, TN, USA., Days E; Vanderbilt Institute of Chemical Biology, Vanderbilt University, Nashville, TN, USA., Bauer JA; Vanderbilt Institute of Chemical Biology, Vanderbilt University, Nashville, TN, USA., Stauffer SR; Center for Therapeutics Discovery, Cleveland Clinic Research, Cleveland, OH, USA. stauffs2@ccf.org.; Department of Pharmacology, Case Western Reserve University, Cleveland, OH, USA. stauffs2@ccf.org., Boudker O; Department of Physiology & Biophysics, Weill Cornell Medicine, New York, NY, USA. olb2003@med.cornell.edu.; Howard Hughes Medical Institute, Weill Cornell Medicine, New York, NY, USA. olb2003@med.cornell.edu., Chakraborty AA; Department of Cancer Sciences, Cleveland Clinic Research, Cleveland, OH, USA. chakraa@ccf.org.; Department of Pharmacology, Case Western Reserve University, Cleveland, OH, USA. chakraa@ccf.org.; Case Comprehensive Cancer Center, Cleveland, OH, USA. chakraa@ccf.org. |
| Source: | The EMBO journal [EMBO J] 2026 Jun; Vol. 45 (11), pp. 3763-3787. Date of Electronic Publication: 2026 Apr 22. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8208664 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1460-2075 (Electronic) Linking ISSN: 02614189 NLM ISO Abbreviation: EMBO J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1460-2075 |
|---|---|
| DOI: | 10.1038/s44318-026-00776-2 |
